Sand Grove Capital Management’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SRDX
Sand Grove Capital Management's SRDX Position: Q4 2025 in Review
Sand Grove Capital Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 129,557 shares — an estimated $3.87M sold.
Sand Grove Capital Management first reported a position in SRDX in Q2 2024 and held it in 2 quarters. The position peaked at $14.9M in Q2 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.
- Sand Grove Capital Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
- Sand Grove Capital Management sold 129,557 Surmodics shares in Q4 2025, an estimated $3.87M.
- Sand Grove Capital Management first reported a position in Surmodics in Q2 2024 and held it in 2 quarters.
- Sand Grove Capital Management's Surmodics position peaked at $14.9M in Q2 2024.
- 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.
Based on Sand Grove Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.